Brief: BioSenic Net Cash At End-Sept At EUR 0.39 Million
Oct 25 (Reuters) - BioSenic BIOS.BR :
* NET CASH AT END OF SEPTEMBER 2023 AMOUNTED TO EUR 0.39
MILLION
* ANTICIPATES HAVING SUFFICIENT CASH TO CARRY OUT ITS
BUSINESS
OBJECTIVES UNTIL END OF JANUARY 2024
Source text for Eikon: ID:nGNE2MQHSY
Further company coverage: BIOS.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Biosenic SA
See all newsBrief: Biosenic Says Enterprise Court Of Nivelles Approves Co's Restructuring Plan
Brief: Biosenic Anticipates Having Sufficient Cash To Carry Out Its Business Objectives Until Q3 2024
Brief: BioSenic Patent Granted In Canada For Broader Protection Of ATO Therapeutic Platform
Brief: Biosenic Files For Additional Patent Protection For Osteoarthritis Drug
Brief: BioSenic Signs New Binding Term Sheet With Phebra PTY Ltd